ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Organ systems Coordinating Center Decision Still Delayed; Branch Merged With DCPC Centers Branch

June 29, 1984

Miami Radiotherapy Program Defended

June 30, 1978

NCI Health Disparities Center Will Attempt To Influence Policy, Harold Freeman Says.

November 3, 2000

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006

Columbia Formally Names As 21st Comprehensive Center

March 9, 1979

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008